Search Results - "Oswald, Kelli A."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin

    Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin by BULL, Elizabeth E. A, DOTE, Hideaki, BRADY, Kristin J, BURGAN, William E, CARTER, Donna J, CERRA, Michael A, OSWALD, Kelli A, HOLLINGSHEAD, Melinda G, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Clinical cancer research (01-12-2004)
    “…Purpose: Because of the potential for affecting multiple signaling pathways, inhibition of Hsp90 may provide a strategy for enhancing tumor cell…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity

    Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity by RUSSELL, Jeffery S, BRADY, Kristin, BURGAN, William E, CERRA, Michael A, OSWALD, Kelli A, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Cancer research (Chicago, Ill.) (01-11-2003)
    “…Rad51 is an essential component of the homologous DNA repair pathway and has been implicated as a determinant of cellular radiosensitivity. Gleevec is a…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin: A multitarget approach to radiosensitization

    Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin: A multitarget approach to radiosensitization by RUSSELL, Jeffery S, BURGAN, William, OSWALD, Kelli A, CAMPHAUSEN, Kevin, TOFILON, Philip J

    Published in Clinical cancer research (01-09-2003)
    “…Current strategies for tumor cell radiosensitization focus on a target-based approach. However, the radioresponse of a tumor cell is influenced by a wide…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275

    Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275 by Camphausen, Kevin, Burgan, William, Cerra, Michael, Oswald, Kelli A., Trepel, Jane B., Lee, Min-Jung, Tofilon, Philip J.

    Published in Cancer research (Chicago, Ill.) (01-01-2004)
    “…Histone deacetylase (HDAC) inhibitors are undergoing clinical evaluation for cancer therapy. Because HDAC modulates chromatin structure and gene expression,…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Enhanced Cell Killing Induced by the Combination of Radiation and the Heat Shock Protein 90 Inhibitor 17-Allylamino-17- Demethoxygeldanamycin

    Enhanced Cell Killing Induced by the Combination of Radiation and the Heat Shock Protein 90 Inhibitor 17-Allylamino-17- Demethoxygeldanamycin by Jeffery S. Russell, William Burgan, Kelli A. Oswald, Kevin Camphausen, Philip J. Tofilon

    Published in Clinical cancer research (01-09-2003)
    “…Purpose: Current strategies for tumor cell radiosensitization focus on a target-based approach. However, the radioresponse of a tumor cell is influenced by a…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275

    Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275 by Camphausen, Kevin, Burgan, William, Cerra, Michael, Oswald, Kelli A, Trepel, Jane B, Lee, Min-Jung, Tofilon, Philip J

    Published in Cancer research (Chicago, Ill.) (01-01-2004)
    “…Histone deacetylase (HDAC) inhibitors are undergoing clinical evaluation for cancer therapy. Because HDAC modulates chromatin structure and gene expression,…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Enhanced radiation-induced cell killing and prolongation of yH2AX foci expression by the histone deacetylase inhibitor MS-275

    Enhanced radiation-induced cell killing and prolongation of yH2AX foci expression by the histone deacetylase inhibitor MS-275 by CAMPHAUSEN, Kevin, BURGAN, William, CERRA, Michael, OSWALD, Kelli A, TREPEL, Jane B, LEE, Min-Jung, TOFILON, Philip J

    Published in Cancer research (Chicago, Ill.) (2004)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: